eMedicine Specialties > Radiology > Brain/Spine

Neurofibromatosis Type 1: Imaging

Author: Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP, Chairman of Medical Imaging, Professor of Radiology, NGHA, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia
Coauthor(s): Ian Turnbull, MD, Lecturer, Department of Radiology, University of Manchester; Consulting Neuroradiologist, Hope Hospital, Salford, Manchester and North Manchester Hospital; Sumaira MacDonald, MBChB, PhD, MRCP, FRCR, Lecturer, Sheffield University Medical School; Endovascular Fellow, Sheffield Vascular Institute; Niranjan Desai, MB, BCh, FRCR, Consultant Radiologist, Department of Diagnostic Radiology, North Manchester General Hospital, UK; Noor Bibi, MBBS, DMRD, Head, Department of Radiology, National Institute for Handicapped; Riyadh Al-Okaili, MBBS, Interventional/Therapeutic and Diagnostic Neuro-Radiologist, King Abdulaziz Medical City
Contributor Information and Disclosures

Updated: Jan 23, 2008

Radiography

Findings

  • Skull
    • Many skull abnormalities are well demonstrated on plain radiographs. These include macrocephaly, absence of the greater and lesser wings of the sphenoid, absence of the orbital floor, hypoplasia of the lesser wings of the sphenoid, enlarged orbits, enlargement of cranial foramina, enlargement of orbital margins, sclerosis in the vicinity of the optic foramen (optic nerve sheath meningioma), facial asymmetry, hypoplasia of the paranasal sinuses, mandibular abnormalities, mandibular hypoplasia with flattening of the external contour, thinning of the ramus, coronoid hyperplasia, widening of the lateral and medial coronoid spaces, and calvarial defects adjacent to the lambdoid suture.
    • Multiple frontobasal osseomeningeal defects causing cerebrospinal fluid (CSF) rhinorrhea and meningoencephalocele can occur, and the osseous defects may be depicted on plain radiographs.
    • Dural calcifications, especially at vertex.
    • Macrocephaly due to hydrocephalus or increased white matter volume.
  • Chest
    • Plain radiograph findings include inferior rib notching, twisted and ribbonlike ribs in the upper thoracic cage, posterior mediastinal masses secondary to intrathoracic meningoceles, mediastinal and lung masses secondary to neurofibromas, and dumbbell neurofibromas.
    • Reported changes of lung parenchyma include progressive pulmonary interstitial fibrosis leading to formation of bullae and honeycomb lung.
    • The incidence of spontaneous pneumothorax and hemothorax is increased.
    • Changes of interstitial lung disease and pulmonary hypertension may be seen, such as dilatation/enlargement of the central pulmonary arteries and peripheral pruning of vessels.
  • Spine
    • A sharply angled kyphoscoliosis centered at the thoracolumbar junction is seen in 50% of patients. The kyphosis is more pronounced than the scoliosis, and the incidence increases with advancing age.
    • Enlargement of the intervertebral foramina, scalloping of the vertebral bodies (anterior, posterior, lateral), hypoplasia of the vertebral pedicles, wedged-shaped vertebrae, spondylolisthesis, spinal clefts, osteolysis, and spindling of the transverse processes may be depicted.
    • Spinal fusion may be complicated by pseudoarthrosis and curve progression.
    • Spinal segments may be unstable, leading to subluxation or dislocation.
  • Appendicular skeleton
    • Bowing or an S-shaped deformity of long bones, hyperplasia or hypoplasia of long and short bones, pseudoarthrosis, erosions, periosteal dysplasia, intramedullary longitudinal osteosclerotic streaks, single or multiple cystic bone lesions, and focal gigantism may be depicted.
    • Joint abnormalities reported include protrusio acetabuli, dislocation of the hip, dislocation of the radius and ulna, absence of a patella, and neuropathic arthropathy of the knee.
  • GI tract
    • Abdominal involvement in NF1 has been described, including neurofibromas within the stomach, small and large bowels, and rectum.
    • Barium series may show intraluminal mass lesions due to a neurofibroma indistinguishable from other polypoid lesions.
    • Intussusception of the bowel may be present with intestinal obstruction.
    • Rarely, bowel obstruction simulating Hirschsprung disease may occur, secondary to plexiform neurofibroma of the colon.
    • Plexiform neurofibromas may cause a mass effect on adjacent barium-filled bowel loops.
    • Small-bowel leiomyoma, small-bowel adenocarcinoma with neuroendocrine function, stromal tumors, and carcinoid tumors are other reported associations.
    • Pseudo-obstruction has been reported.
    • A barium small-bowel series may show features consistent with malabsorption resulting from protein-losing enteropathy.
    • Biliary strictures and bile duct intraluminal neurofibromas are rarely associated and may be revealed on percutaneous cholangiography or endoscopic retrograde cholangiopancreatography (ERCP).32
  • Urinary tract
    • The renal collecting system and bladder may be intrinsically involved by neurofibromas or extrinsically compressed or displaced by neurofibromas.
    • Plain radiography has little to contribute besides showing a soft-tissue mass, but intravenous urography may provide useful information regarding the nature and site of obstruction and function.

Degree of Confidence

Radiographic findings of NF1 are nonspecific, but a fairly confident diagnosis can be made in the appropriate clinical setting when the index of clinical suspicion is high.

False Positives/Negatives

Many neurofibromas may not be depicted on plain radiographs. NF shares many skeletal abnormalities with other syndromes; therefore, the differential diagnosis is extensive.

Computed Tomography

Findings

Peripheral soft-tissue NF

  • CT scans demonstrate solid fusiform masses in the distribution of nerves, with central areas of low attenuation and calcification. These masses may present in the paravertebral, laryngeal, mediastinal, abdominal, and pelvic/ischiorectal fossae. The masses usually are well defined with attenuation values of approximately 30-40 Hounsfield units (HU).
  • Plexiform neurofibromas are depicted as widespread sheets of nodular tissue, with attenuation values identical to the fusiform form (30-40 HU).
  • Paraspinal neurofibromas may be seen at every level, may vary in size, may be dumbbell shaped, or may comprise fusiform/spherical soft-tissue masses with attenuation values of approximately 20-30 HU. Dumbbell-shaped neurofibromas may enlarge the exiting foramina.
  • A characteristic appearance may be seen of mesenteric plexiform neurofibromas trapping mesenteric fat within an entangled network, with attenuation values of approximately 15-30 HU.
  • Nonneoplastic cerebral and cerebellar calcification and choroid plexus calcification are depicted well on cranial CT scans.
  • Hydrocephalus in NF1 may be due to benign aqueduct stenosis or a glioma of the tectum/tegmentum of the mesencephalon.
  • Intracranial nerve sheath tumors are not depicted as well on CT scans as they are on MRI, but associated bone erosions are seen well on CT.
  • Meningiomas with associated changes in the calvarium/skull are depicted well.
  • Dural calcifications may be seen, especially at vertex.
  • Macrocephaly due to hydrocephalus or increased white matter volume may be seen 
  • Extrinsic bladder involvement, intrinsic infiltrative processes, or extrinsic compression of the renal collecting system by a neurofibroma may be revealed on CT scans as masses of low attenuation.
  • CT has a role in the investigation of thoracic, abdominal, and pelvic complications of NF1.

Degree of Confidence

CT scans and MRIs are excellent at depicting most primary lesions and associated tumors and complications of NF1. Some pathology is better imaged by using MRI, such as optic nerve glioma and intraspinal abnormalities. However, even with optic nerve gliomas, osseous erosions may be depicted better on CT scans.27,28,29

False Positives/Negatives

Neurofibromas can occur as an isolated anomaly and in association with NF2. Certain congenital bone lesions may mimic bone involvement associated with NF1, such as fibrous dysplasia. A number of syndromes can mimic NF1 (see Differentials).

Magnetic Resonance Imaging

Findings

  • MRI is the modality of choice for imaging neural sheath tumors, which can be demonstrated by following the course of the nerve from which the tumor arises.
  • Intracranial neural sheath tumors are isointense to brain tissue on T1-weighted images and hyperintense to brain tissue on T2-weighted images.
  • Tumors enhance intensely following contrast administration.
  • Tumors tend to be smoothly marginated.
  • Larger tumors are heterogeneous.
  • Tumors occasionally present at the base of the brain and may spread through the basal foramina.
  • Intraparenchymal brain abnormalities include isointense or hyperintense foci on T2-weighted images in the cerebellar white matter, dentate nucleus, basal ganglia, periventricular white matter, optic nerve, and optic pathways. These lesions are isointense on T1-weighted images and usually have no mass effect. (The lesions are classed as hamartomas but are probably demyelinating lesions because they may resolve.) They become visible between ages 2 and 10 years, then regress by the second decade. If the T2 lesions show enhancement, glioma development should be suspected.
  • Rarely, hyperintensities and mild mass effect have been reported in the globus pallidus on T1-weighted images.
  • Optic gliomas, which are the most common intracranial lesion in NF1, and gliomas of other parts of the brain may be demonstrated.
  • Gliomatosis cerebri may be seen, which is an unusual confluence of astrocytomas.
  • Hydrocephalus in NF1 may be due to benign aqueduct stenosis or a glioma of tectum/tegmentum of the mesencephalon.
  • Dural calcifications may be seen, especially at vertex. 
  • Macrocephaly due to hydrocephalus or increased white matter volume may be seen.
  • Nerve sheath tumors are the most common intradural neoplasms. Schwannomas usually arise from the dorsal sensory root. They are almost always solitary and sporadic in NF1, but multiple schwannomas occur in NF2. Intradural neurofibromas are almost always multiple in NF1.
  • Although schwannomas and neurofibromas are histologically different, they exhibit similar MRI appearances. Both schwannomas and neurofibromas are hypointense or mildly hypointense compared to the spinal cord on T1-weighted images and are heterogeneously hyperintense on T2-weighted images. The tumors may extend into the neural foramina.
    • Within schwannomas, areas of hypointensity due to collagen deposition, hemorrhage, and densely packed Schwann cells frequently are seen.
    • After the administration of contrast material, peripheral enhancement of schwannomas predominates.
    • Neurofibromas enhance more homogeneously.
    • Enhancement patterns and T2-weighted images can help differentiate schwannomas from meningiomas, but the same confidence cannot be transferred to differentiating schwannomas from neurofibromas.
  • MRI allows noninvasive identification of intradural neurofibromas and helps determine their relationship to the neural foramina, canal, and thecal sac spinal cord. 
  • The target sign (bright on T2, with dark collagen centrally) is highly suggestive of a peripheral neurofibroma on MRI. It may be seen with plexiform neurofibromas as well.
  • Paraspinal neurofibromas may be dumbbell shaped, fusiform, or spherical. They are slightly hyperintense relative to muscle on T1-weighted images, with a hyperintense periphery and a hypointense core on T2-weighted images.
  • A lateral thoracic meningocele, which is known to be associated with NF1, is depicted well on MRIs and is seen as a CSF-filled sac extending through a widened neural foramina.
  • Other CNS abnormalities associated with NF1 are depicted well on MRIs and include prominent CSF spaces, arachnoid cysts, arachnoid pouches, frontobasal meningocele, craniofacial plexiform neurofibromas, and intracranial lipoma.
  • Extrinsic bladder involvement, an intrinsic infiltrative process, and extrinsic compression of the renal collecting system by a neurofibroma are depicted well, with a markedly increased signal within the compressing mass on T2-weighted images and a slightly increased signal intensity on T1-weighted images relative to muscle.
  • Cardiovascular abnormalities, such as a superior vena cava aneurysm, obstruction, lymphatic obstruction, left atrial wall aneurysm, aneurysm of the coronary arteries, aneurysm of other major or minor vessels, and stenoses of cranial, renal, celiac axis, and superior mesenteric arteries, are depicted well with magnetic resonance angiography (MRA) or contrast-enhanced dynamic MRA.

Degree of Confidence

MRI is the modality of choice because the course of the nerve from which the tumor arises can be detected, and MRI can depict neural sheath tumors. MRI also depicts optic nerve gliomas better than CT.27,28,29

False Positives/Negatives

Schwannomas and neurofibromas cannot always be differentiated. When solitary, the tumor usually is regarded as a schwannoma; when multiple, tumors usually are diagnosed as neurofibromas.

Ultrasonography

Findings

  • Solitary neurofibromas are mostly hyperechoic with coarse internal echoes and lobulated margins.
  • Nonplexiform neurofibromas in NF1 appear as hypoechoic fusiform masses, and although they do not have a histologic capsule, they present with relatively regular and well-defined margins.
  • Small intratumoral cystic areas due to myxoid degeneration may be present in schwannomas.
  • When a sudden increase in tumor size is detected, malignant transformation should be considered.
  • Paraspinal neurofibromas may appear as well-circumscribed cylindrical lesions.
  • Abdominal involvement that may be depicted on sonography includes NF and tumor growth in the liver, mesentery, and the retroperitoneum, in addition to mesenteric leiomyomatosis and gastric and bowel tumors.
  • Biliary obstruction may be demonstrated on ultrasound images, and tumor spread into the liver along the portal vein has been shown as infiltrative hypoechoic masses around the porta hepatis and intrahepatic portal branches.
  • Similarly, obstructive uropathy caused by neurofibroma may be depicted on ultrasound images.
  • Duplex color and spectral Doppler ultrasonography are useful diagnostic modalities for revealing the vascular complications of NF1, such as aneurysms and stenoses.

Degree of Confidence

The diagnosis of nerve sheath tumors with sonography depends on depiction of a mass along the presumed course of a nerve in association with neurologic signs. Thus, sonography is reliable only when a definite relationship can be demonstrated between a mass and a nerve origin.29

False Positives/Negatives

Peripheral lymphadenopathy may superficially resemble neurofibromas. Lesions within other solid or cystic intra-abdominal organs need to be differentiated from other masses.

Nuclear Imaging

Findings

Radionuclide isotope bone scans can be useful in the investigation of intraosseous lesions and pseudofractures because differentiation from metastases may be possible. Technetium-99m diethylenetriamine pentaacetic acid (DTPA) has been shown to accumulate in benign soft-tissue tumors of NF. Positron emission tomography has been used to image the uptake of fluorodeoxyglucose in the malignant transformation of a neurofibroma.33,34

Degree of Confidence

The role of nuclear medicine is complementary, and the findings are seldom diagnostic.

False Positives/Negatives

Although radionuclide scans are sensitive in detecting bone pathology, the appearances are nonspecific, and positive findings may occur in a variety of bone pathologies.

Angiography

Findings

Angiography remains the criterion standard for providing both anatomic and functional information on vascular aneurysms, occlusions, and arteriovenous shunts.

Degree of Confidence

Aneurysms and stenoses are depicted well on angiographic images, which remain the criterion standard for vascular investigation.

False Positives/Negatives

Although angiography is highly sensitive in the diagnosis of aneurysms and stenoses, findings only occasionally help in specifying the cause.

More on Neurofibromatosis Type 1

Overview: Neurofibromatosis Type 1
Imaging: Neurofibromatosis Type 1
Follow-up: Neurofibromatosis Type 1
Multimedia: Neurofibromatosis Type 1
References

References

  1. Cormier JM, Cormier F, Mayade F, Fichelle JM. [Arterial complications of neurofibromatosis]. J Mal Vasc. Oct 1999;24(4):281-6. [Medline].

  2. Friedman JM, Birch PH. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet. May 16 1997;70(2):138-43. [Medline].

  3. Lloyd S, Saleh HA, Goh V, Ryan R. A new presentation of angiopathy in neurofibromatosis type 1. J Laryngol Otol. Dec 2000;114(12):993-4. [Medline].

  4. Meyer GW, Griffiths WJ, Welsh J, et al. Hepatobiliary involvement in von Recklinghausen''s disease. Ann Intern Med. Nov 1982;97(5):722-3. [Medline].

  5. NIH. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. May 1988;45(5):575-8. [Medline].

  6. Rossi SE, Erasmus JJ, McAdams HP, Donnelly LF. Thoracic manifestations of neurofibromatosis-I. AJR Am J Roentgenol. Dec 1999;173(6):1631-8. [Medline].

  7. Steenbrugge F, Verstraete K, Poffyn B, et al. Recurrent massive subperiosteal hematoma in a patient with neurofibromatosis. Eur Radiol. 2001;11(3):480-3. [Medline].

  8. Tatemichi M, Nagata H, Morinaga S, Kaneda S. Protein-losing enteropathy caused by mesenteric vascular involvement of neurofibromatosis. Dig Dis Sci. Aug 1993;38(8):1549-53. [Medline].

  9. Tins B, Greaves M, Bowling T. Neurofibromatosis associated with a coronary artery aneurysm. Br J Radiol. Nov 2000;73(875):1219-20. [Medline].

  10. McClatchey AI. Neurofibromatosis. Annu Rev Pathol. 2007;2:191-216. [Medline].

  11. Dugoff L, Sujansky E. Neurofibromatosis type 1 and pregnancy. Am J Med Genet. Dec 2 1996;66(1):7-10. [Medline].

  12. Lin AE, Birch PH, Korf BR, et al. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet. Nov 13 2000;95(2):108-17. [Medline].

  13. Trevelyan J, Been M, Patel R. Multiple coronary aneurysms in a patient with neurofibromatosis type 1: case report and intravascular ultrasound of aneurysm. Postgrad Med J. Jan 2001;77(903):45-7. [Medline].

  14. Grouls V, Vaih S, Bindewald H. [Involvement of the large intestine in neurofibromatosis type 1]. Pathologe. Mar 1996;17(2):133-8. [Medline].

  15. Sato M, Ishida H, Konno K, et al. Abdominal involvement in neurofibromatosis 1: sonographic findings. Abdom Imaging. Sep-Oct 2000;25(5):517-22. [Medline].

  16. Sinha SK, Kochhar R, Rana S, et al. Intestinal pseudo-obstruction due to neurofibromatosis responding to cisapride. Indian J Gastroenterol. Apr-Jun 2000;19(2):83-4. [Medline].

  17. Riffaud L, Vinchon M, Ragragui O. Hemispheric cerebral gliomas in children with NF1: arguments for a long- term follow-up. Childs Nerv Syst. Feb 2002;18(1-2):43-7. [Medline].

  18. Obringer AC, Meadows AT, Zackai EH. The diagnosis of neurofibromatosis-1 in the child under the age of 6 years. Am J Dis Child. Jun 1989;143(6):717-9. [Medline].

  19. Syrbe S, Eberle K, Strenge S, Bernhard MK, Herbertz S, Bierbach U. [Neurofibromatosis type 1 and associated clinical abnormalities in 27 children]. Klin Padiatr. Nov-Dec 2007;219(6):326-32. [Medline].

  20. Dahnart Wolfgang. Radiology Review Manual. 6th Edition. Philadelphia: Lippincott William & Wilkins; 2007:316-318.

  21. Kim HR, Kim YJ. Neurofibromatosis of the colon and rectum combined with other manifestations of von Recklinghausen''s disease: report of a case. Dis Colon Rectum. Sep 1998;41(9):1187-92. [Medline].

  22. Maertens O, Brems H, Vandesompele J, De Raedt T, Heyns I, Rosenbaum T. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum Mutat. Oct 2006;27(10):1030-40. [Medline].

  23. Rasmussen SA, Yang Q, Friedman JM. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet. May 2001;68(5):1110-8. [Medline].

  24. Elster AD. Radiologic screening in the neurocutaneous syndromes: strategies and controversies. AJNR Am J Neuroradiol. Jul-Aug 1992;13(4):1078-82. [Medline].

  25. Artaza T, Garcia JF, Gonzalez C, et al. Simultaneous involvement of the jejunum and the colon by type-1 neurofibromatosis. Scand J Gastroenterol. Mar 1999;34(3):331-4. [Medline].

  26. Kordic R, Sabol Z, Cerovski B, Katusic D, Jukic T. Eye disorders in neurofibromatosis (NF1). Coll Antropol. 2005;29 Suppl 1:29-31. [Medline].

  27. Dachman AH. CT in neurofibromatosis type I. AJR Am J Roentgenol. Dec 2000;175(6):1748. [Medline].

  28. Jain R, Sawhney S, Berry M. Mesenteric plexiform neurofibroma: computed tomography appearance. Australas Radiol. May 1996;40(2):158-9. [Medline].

  29. Lin J, Martel W. Cross-sectional imaging of peripheral nerve sheath tumors: characteristic signs on CT, MR imaging, and sonography. AJR Am J Roentgenol. Jan 2001;176(1):75-82. [Medline].

  30. Solomon SB, Semih Dogan A, Nicol TL, et al. Positron emission tomography in the detection and management of sarcomatous transformation in neurofibromatosis. Clin Nucl Med. Jun 2001;26(6):525-8. [Medline].

  31. Daffner RH. Fibrous dysplasia. Contemporary Diagnostic Radiology. June 2002;25:1-4.

  32. Taylor MA, Loughrey MB, Toner PG, Regan MC. An unusual cause of biliary stricture in a patient with neurofibromatosis type 1. Eur J Gastroenterol Hepatol. Feb 2001;13(2):199-201. [Medline].

  33. Buchert R, von Borczyskowski D, Wilke F, Gronowsky M, Friedrich RE, Brenner W. Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1. Nucl Med Commun. Jan 2008;29(1):17-26. [Medline].

  34. Ferner RE, Golding JF, Smith M, Calonje E, Jan W, Sanjayanathan V. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Ann Oncol. Oct 11 2007;[Medline].

Further Reading

Keywords

NF, NF1, NF-1, von Recklinghausen disease, von Recklinghausen syndrome, von Recklinghausen's disease, von Recklinghausen's syndrome, elephant man, nerve sheath tumor, neurofibromas

Contributor Information and Disclosures

Author

Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP, Chairman of Medical Imaging, Professor of Radiology, NGHA, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia
Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP is a member of the following medical societies: American Institute of Ultrasound in Medicine, Radiological Society of North America, Royal College of Physicians, Royal College of Physicians and Surgeons of the United States, Royal College of Radiologists, and Royal College of Surgeons of England
Disclosure: Nothing to disclose.

Coauthor(s)

Ian Turnbull, MD, Lecturer, Department of Radiology, University of Manchester; Consulting Neuroradiologist, Hope Hospital, Salford, Manchester and North Manchester Hospital
Disclosure: Nothing to disclose.

Sumaira MacDonald, MBChB, PhD, MRCP, FRCR, Lecturer, Sheffield University Medical School; Endovascular Fellow, Sheffield Vascular Institute
Sumaira MacDonald, MBChB, PhD, MRCP, FRCR is a member of the following medical societies: British Medical Association, Royal College of Physicians, and Royal College of Radiologists
Disclosure: Nothing to disclose.

Niranjan Desai, MB, BCh, FRCR, Consultant Radiologist, Department of Diagnostic Radiology, North Manchester General Hospital, UK
Niranjan Desai, MB, BCh, FRCR is a member of the following medical societies: American Roentgen Ray Society, Radiological Society of North America, and Royal College of Radiologists
Disclosure: Nothing to disclose.

Noor Bibi, MBBS, DMRD, Head, Department of Radiology, National Institute for Handicapped
Disclosure: Nothing to disclose.

Riyadh Al-Okaili, MBBS, Interventional/Therapeutic and Diagnostic Neuro-Radiologist, King Abdulaziz Medical City
Riyadh Al-Okaili, MBBS is a member of the following medical societies: American College of Radiology
Disclosure: Nothing to disclose.

Medical Editor

Mahesh R Patel, MD, Chief of MRI, Department of Radiology, Santa Clara Valley Medical Center
Mahesh R Patel, MD is a member of the following medical societies: Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Robert L DeLaPaz, MD, Director, Professor, Department of Radiology, Division of Neuroradiology, Columbia University
Robert L DeLaPaz, MD is a member of the following medical societies: American Society of Neuroradiology, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

James G Smirniotopoulos, MD, Professor of Radiology, Neurology, and Biomedical Informatics, Chairman, Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences
James G Smirniotopoulos, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, American Society of Head and Neck Radiology, American Society of Neuroradiology, American Society of Pediatric Neuroradiology, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.